# Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia

> **NCT07384936** · NA · NOT_YET_RECRUITING · sponsor: **Fang Wang** · enrollment: 100 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Topefilgrastim Injection
- **DRUG:** Topefilgrastim Injection

## Key facts

- **NCT ID:** NCT07384936
- **Lead sponsor:** Fang Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-31
- **Primary completion:** 2027-05
- **Final completion:** 2027-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384936, "Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07384936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*